Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1958 1
1964 1
1966 1
1970 1
1971 2
1972 2
1973 1
1974 1
1975 3
1977 2
1978 1
1985 1
1986 1
1988 2
1990 1
1991 3
1993 3
1994 2
1995 2
1996 2
1997 3
1998 5
1999 6
2000 4
2001 4
2002 1
2003 2
2004 4
2005 8
2006 10
2007 7
2008 14
2009 7
2010 8
2011 7
2012 13
2013 13
2014 13
2015 9
2016 6
2017 5
2018 9
2019 10
2020 7
2021 8
2022 9
2023 5
2024 6
2025 6

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

219 results

Results by year

Filters applied: . Clear all
Page 1
Risankizumab versus Ustekinumab for Moderate-to-Severe Crohn's Disease.
Peyrin-Biroulet L, Chapman JC, Colombel JF, Caprioli F, D'Haens G, Ferrante M, Schreiber S, Atreya R, Danese S, Lindsay JO, Bossuyt P, Siegmund B, Irving PM, Panaccione R, Cao Q, Neimark E, Wallace K, Anschutz T, Kligys K, Duan WR, Pivorunas V, Huang X, Berg S, Shu L, Dubinsky M; SEQUENCE Study Group. Peyrin-Biroulet L, et al. N Engl J Med. 2024 Jul 18;391(3):213-223. doi: 10.1056/NEJMoa2314585. N Engl J Med. 2024. PMID: 39018531 Clinical Trial.
Phase 2 Trial of Anti-TL1A Monoclonal Antibody Tulisokibart for Ulcerative Colitis.
Sands BE, Feagan BG, Peyrin-Biroulet L, Danese S, Rubin DT, Laurent O, Luo A, Nguyen DD, Lu J, Yen M, Leszczyszyn J, Kempiński R, McGovern DPB, Ma C, Ritter TE, Targan S; ARTEMIS-UC Study Group. Sands BE, et al. N Engl J Med. 2024 Sep 26;391(12):1119-1129. doi: 10.1056/NEJMoa2314076. N Engl J Med. 2024. PMID: 39321363 Clinical Trial.
Infliximab-Related Infusion Reactions: Systematic Review.
Lichtenstein L, Ron Y, Kivity S, Ben-Horin S, Israeli E, Fraser GM, Dotan I, Chowers Y, Confino-Cohen R, Weiss B. Lichtenstein L, et al. Among authors: israeli e. J Crohns Colitis. 2015 Sep;9(9):806-15. doi: 10.1093/ecco-jcc/jjv096. Epub 2015 Jun 19. J Crohns Colitis. 2015. PMID: 26092578 Free PMC article.
Guselkumab in patients with moderately to severely active ulcerative colitis (QUASAR): phase 3 double-blind, randomised, placebo-controlled induction and maintenance studies.
Rubin DT, Allegretti JR, Panés J, Shipitofsky N, Yarandi SS, Huang KG, Germinaro M, Wilson R, Zhang H, Johanns J, Feagan BG, Hisamatsu T, Lichtenstein GR, Bressler B, Peyrin-Biroulet L, Sands BE, Dignass A; QUASAR Study Group. Rubin DT, et al. Lancet. 2025 Jan 4;405(10472):33-49. doi: 10.1016/S0140-6736(24)01927-5. Epub 2024 Dec 17. Lancet. 2025. PMID: 39706209 Clinical Trial.
Vaccines and autoimmunity.
Agmon-Levin N, Paz Z, Israeli E, Shoenfeld Y. Agmon-Levin N, et al. Among authors: israeli e. Nat Rev Rheumatol. 2009 Nov;5(11):648-52. doi: 10.1038/nrrheum.2009.196. Nat Rev Rheumatol. 2009. PMID: 19865091 Review.
The altered lipidome of hepatocellular carcinoma.
Tan SLW, Israeli E, Ericksen RE, Chow PKH, Han W. Tan SLW, et al. Among authors: israeli e. Semin Cancer Biol. 2022 Nov;86(Pt 3):445-456. doi: 10.1016/j.semcancer.2022.02.004. Epub 2022 Feb 4. Semin Cancer Biol. 2022. PMID: 35131480 Review.
Adjuvants and autoimmunity.
Israeli E, Agmon-Levin N, Blank M, Shoenfeld Y. Israeli E, et al. Lupus. 2009 Nov;18(13):1217-25. doi: 10.1177/0961203309345724. Lupus. 2009. PMID: 19880572 Review.
I-CARE, a European Prospective Cohort Study Assessing Safety and Effectiveness of Biologics in Inflammatory Bowel Disease.
Peyrin-Biroulet L, Rahier JF, Kirchgesner J, Abitbol V, Shaji S, Armuzzi A, Karmiris K, Gisbert JP, Bossuyt P, Helwig U, Burisch J, Yanai H, Doherty GA, Magro F, Molnar T, Löwenberg M, Halfvarson J, Zagorowicz E, Rousseau H, Baumann C, Baert F, Beaugerie L; I-CARE Collaborator Group. Peyrin-Biroulet L, et al. Clin Gastroenterol Hepatol. 2023 Mar;21(3):771-788.e10. doi: 10.1016/j.cgh.2022.09.018. Epub 2022 Sep 22. Clin Gastroenterol Hepatol. 2023. PMID: 36152897 Free article.
[The ribosome race].
Israeli E. Israeli E. Harefuah. 2000 Jun 15;138(12):1037-8. Harefuah. 2000. PMID: 10979429 Hebrew. No abstract available.
Endocannabinoids and liver disease--review.
Gabbay E, Avraham Y, Ilan Y, Israeli E, Berry EM. Gabbay E, et al. Among authors: israeli e. Liver Int. 2005 Oct;25(5):921-6. doi: 10.1111/j.1478-3231.2005.01180.x. Liver Int. 2005. PMID: 16162147 Review.
219 results